320 related articles for article (PubMed ID: 33119197)
1. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets?
Campbell RA; Boilard E; Rondina MT
J Thromb Haemost; 2021 Jan; 19(1):46-50. PubMed ID: 33119197
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism.
Shen S; Zhang J; Fang Y; Lu S; Wu J; Zheng X; Deng F
J Hematol Oncol; 2021 Apr; 14(1):72. PubMed ID: 33926500
[TBL] [Abstract][Full Text] [Related]
3. Platelets and COVID-19.
Rohlfing AK; Rath D; Geisler T; Gawaz M
Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic short linear motifs in ACE2 and integrin β
Kliche J; Kuss H; Ali M; Ivarsson Y
Sci Signal; 2021 Jan; 14(665):. PubMed ID: 33436498
[TBL] [Abstract][Full Text] [Related]
5. In well-differentiated primary human bronchial epithelial cells, TGF-
O'Sullivan MJ; Mitchel JA; Mwase C; McGill M; Kanki P; Park JA
Am J Physiol Lung Cell Mol Physiol; 2021 Feb; 320(2):L246-L253. PubMed ID: 33174447
[TBL] [Abstract][Full Text] [Related]
6. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications.
Mészáros B; Sámano-Sánchez H; Alvarado-Valverde J; Čalyševa J; Martínez-Pérez E; Alves R; Shields DC; Kumar M; Rippmann F; Chemes LB; Gibson TJ
Sci Signal; 2021 Jan; 14(665):. PubMed ID: 33436497
[TBL] [Abstract][Full Text] [Related]
7. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.
Ricardo Criado P; Pincelli TPH; Criado RFJ; Abdalla BMZ; Belda Junior W
Exp Dermatol; 2020 Oct; 29(10):936-944. PubMed ID: 32867008
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV 2; Possible alternative virus receptors and pathophysiological determinants.
Pruimboom L
Med Hypotheses; 2021 Jan; 146():110368. PubMed ID: 33189453
[TBL] [Abstract][Full Text] [Related]
10. Blood clots in COVID-19 patients: Simplifying the curious mystery.
Biswas S; Thakur V; Kaur P; Khan A; Kulshrestha S; Kumar P
Med Hypotheses; 2021 Jan; 146():110371. PubMed ID: 33223324
[TBL] [Abstract][Full Text] [Related]
11. Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects.
Drozdzik A; Drozdzik M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163355
[TBL] [Abstract][Full Text] [Related]
12. Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.
Huang C; Jiang Y; Yan J
J Med Virol; 2021 Sep; 93(9):5487-5504. PubMed ID: 33974296
[TBL] [Abstract][Full Text] [Related]
13. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Initiates Programmed Cell Death in Platelets.
Koupenova M; Corkrey HA; Vitseva O; Tanriverdi K; Somasundaran M; Liu P; Soofi S; Bhandari R; Godwin M; Parsi KM; Cousineau A; Maehr R; Wang JP; Cameron SJ; Rade J; Finberg RW; Freedman JE
Circ Res; 2021 Sep; 129(6):631-646. PubMed ID: 34293929
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia alters the expression of ACE2 and TMPRSS2 SARS-CoV-2 cell entry mediators in hCMEC/D3 brain endothelial cells.
Imperio GE; Lye P; Mughis H; Hamada H; Bloise E; Lye SJ; Matthews SG
Microvasc Res; 2021 Nov; 138():104232. PubMed ID: 34416267
[TBL] [Abstract][Full Text] [Related]
16. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.
Karnik M; Beeraka NM; Uthaiah CA; Nataraj SM; Bettadapura ADS; Aliev G; Madhunapantula SV
Mol Neurobiol; 2021 Sep; 58(9):4535-4563. PubMed ID: 34089508
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
[TBL] [Abstract][Full Text] [Related]
18. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.
Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH
Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788
[TBL] [Abstract][Full Text] [Related]
19. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
